IP Library Assignment 059673/0168
Patent Assignment
Reel/Frame 059673/0168

Assignment of Assignor's Interest

Recorded: 2022-04-22 Pages: 5
Assignor
ADC THERAPEUTICS SA
Executed: 2018-05-25
Assignee
MEDIMMUNE LIMITED
MILSTEIN BUILDING, GRANTA PARK, CAMBRIDGE, CB21 6GH, UNITED KINGDOM
Covered Property (1)
Pyrrolobenzodiazepine-Antibody Conjugates
Application: 17/484,467 →
Publication: US 2022/0008552
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Apr 22, 2022
From: VAN BERKEL, PATRICIUS HENDRIKUS CORNELIS
To: ADC THERAPEUTICS (UK) LIMITED
Reel/Frame 059673/0158 →
Assignment of Assignor's Interest Apr 22, 2022
From: ADC THERAPEUTICS (UK) LIMITED
To: ADC THERAPEUTICS SA
Reel/Frame 059673/0163 →
Patent Security Agreement Dec 27, 2022
From: ADC THERAPEUTICS SA
To: OWL ROCK OPPORTUNISTIC MASTER FUND I, L.P.
Reel/Frame 062228/0763 →
Patent Security Agreement Jul 7, 2025
From: ADC THERAPEUTICS SA
To: BLUE OWL OPPORTUNISTIC MASTER FUND I, L.P. (FORMERLY KNOWN AS OWL ROCK OPPORTUNISTIC MASTER FUND I, L.P.)
Reel/Frame 071832/0069 →